APO Research, Inc.

APO RESEARCH · REPORT

HMO Formula

Selected research

Market Analysis & Forecast

Global HMO Formula Market Analysis and Forecast 2026-2032

Market perspective

The global HMO Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HMO Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HMO Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HMO Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HMO Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of HMO Formula include Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso) and Yili Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for HMO Formula, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HMO Formula, also provides the sales of main regions and countries. Of the upcoming market potential for HMO Formula, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HMO Formula sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HMO Formula market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for HMO Formula sales, projected growth trends, production technology, application and end-user industry.

HMO Formula Segment by Company

Abbott

Mead Johnson (Reckitt)

Nestlé

Danone

FrieslandCampina(Friso)

Yili Group

HMO Formula Segment by Type

Powder

Liquid

HMO Formula Segment by Application

Online Sales

Offline Sales

HMO Formula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HMO Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HMO Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HMO Formula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of HMO Formula in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of HMO Formula manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HMO Formula sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HMO Formula Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Powder Major Manufacturers Table 3. Liquid Major Manufacturers Table 4. Global HMO Formula Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Online Sales Major Manufacturers Table 6. Offline Sales Major Manufacturers Table 7. HMO Formula Industry Trends Table 8. HMO Formula Industry Drivers Table 9. HMO Formula Industry Opportunities and Challenges Table 10. HMO Formula Industry Restraints Table 11. Global HMO Formula Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global HMO Formula Revenue by Region (2021-2026) & (US$ Million) Table 13. Global HMO Formula Revenue by Region (2027-2032) & (US$ Million) Table 14. Global HMO Formula Revenue Market Share by Region (2021-2026) Table 15. Global HMO Formula Revenue Market Share by Region (2027-2032) Table 16. Global HMO Formula Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kt) Table 17. Global HMO Formula Sales by Region (2021-2026) & (kt) Table 18. Global HMO Formula Sales by Region (2027-2032) & (kt) Table 19. Global HMO Formula Sales Market Share by Region (2021-2026) Table 20. Global HMO Formula Sales Market Share by Region (2027-2032) Table 21. Global HMO Formula Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global HMO Formula Revenue Market Share by Manufacturers (2021-2026) Table 23. Global HMO Formula Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global HMO Formula Sales Market Share by Manufacturers (2021-2026) Table 25. Global HMO Formula Sales Price (USD/t) of Manufacturers (2021-2026) Table 26. Global HMO Formula Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global HMO Formula Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global HMO Formula Manufacturers, Product Type & Application Table 29. Global HMO Formula Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global HMO Formula by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global HMO Formula Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global HMO Formula Revenue by Type (2021-2026) & (US$ Million) Table 34. Global HMO Formula Revenue by Type (2027-2032) & (US$ Million) Table 35. Global HMO Formula Revenue Market Share by Type (2021-2026) Table 36. Global HMO Formula Revenue Market Share by Type (2027-2032) Table 37. Global HMO Formula Sales by Type 2021 VS 2025 VS 2032 (kt) Table 38. Global HMO Formula Sales by Type (2021-2026) & (kt) Table 39. Global HMO Formula Sales by Type (2027-2032) & (kt) Table 40. Global HMO Formula Sales Market Share by Type (2021-2026) Table 41. Global HMO Formula Sales Market Share by Type (2027-2032) Table 42. Global HMO Formula Price by Type (2021-2026) & (USD/t) Table 43. Global HMO Formula Price by Type (2027-2032) & (USD/t) Table 44. Global HMO Formula Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global HMO Formula Revenue by Application (2021-2026) & (US$ Million) Table 46. Global HMO Formula Revenue by Application (2027-2032) & (US$ Million) Table 47. Global HMO Formula Revenue Market Share by Application (2021-2026) Table 48. Global HMO Formula Revenue Market Share by Application (2027-2032) Table 49. Global HMO Formula Sales by Application 2021 VS 2025 VS 2032 (kt) Table 50. Global HMO Formula Sales by Application (2021-2026) & (kt) Table 51. Global HMO Formula Sales by Application (2027-2032) & (kt) Table 52. Global HMO Formula Sales Market Share by Application (2021-2026) Table 53. Global HMO Formula Sales Market Share by Application (2027-2032) Table 54. Global HMO Formula Price by Application (2021-2026) & (USD/t) Table 55. Global HMO Formula Price by Application (2027-2032) & (USD/t) Table 56. Abbott Company Information Table 57. Abbott Business Overview Table 58. Abbott HMO Formula Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 59. Abbott HMO Formula Product Portfolio Table 60. Abbott Recent Development Table 61. Mead Johnson (Reckitt) Company Information Table 62. Mead Johnson (Reckitt) Business Overview Table 63. Mead Johnson (Reckitt) HMO Formula Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 64. Mead Johnson (Reckitt) HMO Formula Product Portfolio Table 65. Mead Johnson (Reckitt) Recent Development Table 66. Nestlé Company Information Table 67. Nestlé Business Overview Table 68. Nestlé HMO Formula Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Nestlé HMO Formula Product Portfolio Table 70. Nestlé Recent Development Table 71. Danone Company Information Table 72. Danone Business Overview Table 73. Danone HMO Formula Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Danone HMO Formula Product Portfolio Table 75. Danone Recent Development Table 76. FrieslandCampina(Friso) Company Information Table 77. FrieslandCampina(Friso) Business Overview Table 78. FrieslandCampina(Friso) HMO Formula Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. FrieslandCampina(Friso) HMO Formula Product Portfolio Table 80. FrieslandCampina(Friso) Recent Development Table 81. Yili Group Company Information Table 82. Yili Group Business Overview Table 83. Yili Group HMO Formula Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Yili Group HMO Formula Product Portfolio Table 85. Yili Group Recent Development Table 86. North America HMO Formula Revenue by Type (2021-2026) & (US$ Million) Table 87. North America HMO Formula Revenue by Type (2027-2032) & (US$ Million) Table 88. North America HMO Formula Sales by Type (2021-2026) & (kt) Table 89. North America HMO Formula Sales by Type (2027-2032) & (kt) Table 90. North America HMO Formula Sales Price by Type (2021-2026) & (USD/t) Table 91. North America HMO Formula Sales Price by Type (2027-2032) & (USD/t) Table 92. North America HMO Formula Revenue by Application (2021-2026) & (US$ Million) Table 93. North America HMO Formula Revenue by Application (2027-2032) & (US$ Million) Table 94. North America HMO Formula Sales by Application (2021-2026) & (kt) Table 95. North America HMO Formula Sales by Application (2027-2032) & (kt) Table 96. North America HMO Formula Sales Price by Application (2021-2026) & (USD/t) Table 97. North America HMO Formula Sales Price by Application (2027-2032) & (USD/t) Table 98. North America HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America HMO Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America HMO Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America HMO Formula Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 102. North America HMO Formula Sales by Country (2021-2026) & (kt) Table 103. North America HMO Formula Sales by Country (2027-2032) & (kt) Table 104. North America HMO Formula Sales Price by Country (2021-2026) & (USD/t) Table 105. North America HMO Formula Sales Price by Country (2027-2032) & (USD/t) Table 106. United States HMO Formula Revenue (2021-2032) & (US$ Million) Table 107. Canada HMO Formula Revenue (2021-2032) & (US$ Million) Table 108. Mexico HMO Formula Revenue (2021-2032) & (US$ Million) Table 109. Europe HMO Formula Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe HMO Formula Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe HMO Formula Sales by Type (2021-2026) & (kt) Table 112. Europe HMO Formula Sales by Type (2027-2032) & (kt) Table 113. Europe HMO Formula Sales Price by Type (2021-2026) & (USD/t) Table 114. Europe HMO Formula Sales Price by Type (2027-2032) & (USD/t) Table 115. Europe HMO Formula Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe HMO Formula Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe HMO Formula Sales by Application (2021-2026) & (kt) Table 118. Europe HMO Formula Sales by Application (2027-2032) & (kt) Table 119. Europe HMO Formula Sales Price by Application (2021-2026) & (USD/t) Table 120. Europe HMO Formula Sales Price by Application (2027-2032) & (USD/t) Table 121. Europe HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe HMO Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe HMO Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe HMO Formula Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 125. Europe HMO Formula Sales by Country (2021-2026) & (kt) Table 126. Europe HMO Formula Sales by Country (2027-2032) & (kt) Table 127. Europe HMO Formula Sales Price by Country (2021-2026) & (USD/t) Table 128. Europe HMO Formula Sales Price by Country (2027-2032) & (USD/t) Table 129. Germany HMO Formula Revenue (2021-2032) & (US$ Million) Table 130. France HMO Formula Revenue (2021-2032) & (US$ Million) Table 131. U.K. HMO Formula Revenue (2021-2032) & (US$ Million) Table 132. Italy HMO Formula Revenue (2021-2032) & (US$ Million) Table 133. Russia HMO Formula Revenue (2021-2032) & (US$ Million) Table 134. Spain HMO Formula Revenue (2021-2032) & (US$ Million) Table 135. Netherlands HMO Formula Revenue (2021-2032) & (US$ Million) Table 136. Switzerland HMO Formula Revenue (2021-2032) & (US$ Million) Table 137. Sweden HMO Formula Revenue (2021-2032) & (US$ Million) Table 138. Poland HMO Formula Revenue (2021-2032) & (US$ Million) Table 139. China HMO Formula Revenue by Type (2021-2026) & (US$ Million) Table 140. China HMO Formula Revenue by Type (2027-2032) & (US$ Million) Table 141. China HMO Formula Sales by Type (2021-2026) & (kt) Table 142. China HMO Formula Sales by Type (2027-2032) & (kt) Table 143. China HMO Formula Sales Price by Type (2021-2026) & (USD/t) Table 144. China HMO Formula Sales Price by Type (2027-2032) & (USD/t) Table 145. China HMO Formula Revenue by Application (2021-2026) & (US$ Million) Table 146. China HMO Formula Revenue by Application (2027-2032) & (US$ Million) Table 147. China HMO Formula Sales by Application (2021-2026) & (kt) Table 148. China HMO Formula Sales by Application (2027-2032) & (kt) Table 149. China HMO Formula Sales Price by Application (2021-2026) & (USD/t) Table 150. China HMO Formula Sales Price by Application (2027-2032) & (USD/t) Table 151. Asia HMO Formula Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia HMO Formula Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia HMO Formula Sales by Type (2021-2026) & (kt) Table 154. Asia HMO Formula Sales by Type (2027-2032) & (kt) Table 155. Asia HMO Formula Sales Price by Type (2021-2026) & (USD/t) Table 156. Asia HMO Formula Sales Price by Type (2027-2032) & (USD/t) Table 157. Asia HMO Formula Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia HMO Formula Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia HMO Formula Sales by Application (2021-2026) & (kt) Table 160. Asia HMO Formula Sales by Application (2027-2032) & (kt) Table 161. Asia HMO Formula Sales Price by Application (2021-2026) & (USD/t) Table 162. Asia HMO Formula Sales Price by Application (2027-2032) & (USD/t) Table 163. Asia HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia HMO Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia HMO Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia HMO Formula Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 167. Asia HMO Formula Sales by Country (2021-2026) & (kt) Table 168. Asia HMO Formula Sales by Country (2027-2032) & (kt) Table 169. Asia HMO Formula Sales Price by Country (2021-2026) & (USD/t) Table 170. Asia HMO Formula Sales Price by Country (2027-2032) & (USD/t) Table 171. Japan HMO Formula Revenue (2021-2032) & (US$ Million) Table 172. South Korea HMO Formula Revenue (2021-2032) & (US$ Million) Table 173. India HMO Formula Revenue (2021-2032) & (US$ Million) Table 174. Australia HMO Formula Revenue (2021-2032) & (US$ Million) Table 175. Taiwan HMO Formula Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia HMO Formula Revenue (2021-2032) & (US$ Million) Table 177. SAMEA HMO Formula Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA HMO Formula Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA HMO Formula Sales by Type (2021-2026) & (kt) Table 180. SAMEA HMO Formula Sales by Type (2027-2032) & (kt) Table 181. SAMEA HMO Formula Sales Price by Type (2021-2026) & (USD/t) Table 182. SAMEA HMO Formula Sales Price by Type (2027-2032) & (USD/t) Table 183. SAMEA HMO Formula Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA HMO Formula Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA HMO Formula Sales by Application (2021-2026) & (kt) Table 186. SAMEA HMO Formula Sales by Application (2027-2032) & (kt) Table 187. SAMEA HMO Formula Sales Price by Application (2021-2026) & (USD/t) Table 188. SAMEA HMO Formula Sales Price by Application (2027-2032) & (USD/t) Table 189. SAMEA HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA HMO Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA HMO Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA HMO Formula Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 193. SAMEA HMO Formula Sales by Country (2021-2026) & (kt) Table 194. SAMEA HMO Formula Sales by Country (2027-2032) & (kt) Table 195. SAMEA HMO Formula Sales Price by Country (2021-2026) & (USD/t) Table 196. SAMEA HMO Formula Sales Price by Country (2027-2032) & (USD/t) Table 197. Brazil HMO Formula Revenue (2021-2032) & (US$ Million) Table 198. Argentina HMO Formula Revenue (2021-2032) & (US$ Million) Table 199. Chile HMO Formula Revenue (2021-2032) & (US$ Million) Table 200. Colombia HMO Formula Revenue (2021-2032) & (US$ Million) Table 201. Peru HMO Formula Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia HMO Formula Revenue (2021-2032) & (US$ Million) Table 203. Israel HMO Formula Revenue (2021-2032) & (US$ Million) Table 204. UAE HMO Formula Revenue (2021-2032) & (US$ Million) Table 205. Turkey HMO Formula Revenue (2021-2032) & (US$ Million) Table 206. Iran HMO Formula Revenue (2021-2032) & (US$ Million) Table 207. Egypt HMO Formula Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. HMO Formula Distributors List Table 211. HMO Formula Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. HMO Formula Image Figure 2. Global HMO Formula Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HMO Formula Market Size Share 2021 VS 2025 VS 2032 Figure 4. Powder Image Figure 5. Liquid Image Figure 6. Global HMO Formula Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global HMO Formula Market Size Share 2021 VS 2025 VS 2032 Figure 8. Online Sales Image Figure 9. Offline Sales Image Figure 10. Global HMO Formula Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global HMO Formula Revenue (2021-2032) & (US$ Million) Figure 12. Global HMO Formula Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global HMO Formula Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global HMO Formula Revenue Market Share by Region (2021-2032) Figure 15. Global HMO Formula Sales (2021-2032) & (kt) Figure 16. Global HMO Formula Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 17. Global HMO Formula Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico HMO Formula Sales YoY (2021-2032) & (kt) Figure 19. Europe HMO Formula Sales YoY (2021-2032) & (kt) Figure 20. China HMO Formula Sales YoY (2021-2032) & (kt) Figure 21. Asia (Excluding China) HMO Formula Sales YoY (2021-2032) & (kt) Figure 22. South America, Middle East and Africa HMO Formula Sales YoY (2021-2032) & (kt) Figure 23. Global HMO Formula Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global HMO Formula Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global HMO Formula Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global HMO Formula Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global HMO Formula Revenue Market Share by Type (2021-2032) Figure 29. Global HMO Formula Sales by Type (2021 VS 2025 VS 2032) & (kt) Figure 30. Global HMO Formula Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global HMO Formula Sales Market Share by Type (2021-2032) Figure 32. Global HMO Formula Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global HMO Formula Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global HMO Formula Revenue Market Share by Application (2021-2032) Figure 35. Global HMO Formula Sales by Application (2021 VS 2025 VS 2032) & (kt) Figure 36. Global HMO Formula Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global HMO Formula Sales Market Share by Application (2021-2032) Figure 38. North America HMO Formula Revenue Share by Type (2021-2032) Figure 39. North America HMO Formula Sales Share by Type (2021-2032) Figure 40. North America HMO Formula Revenue Share by Application (2021-2032) Figure 41. North America HMO Formula Sales Share by Application (2021-2032) Figure 42. North America HMO Formula Revenue Share by Country (2021-2032) Figure 43. North America HMO Formula Sales Share by Country (2021-2032) Figure 44. Europe HMO Formula Revenue Share by Type (2021-2032) Figure 45. Europe HMO Formula Sales Share by Type (2021-2032) Figure 46. Europe HMO Formula Revenue Share by Application (2021-2032) Figure 47. Europe HMO Formula Sales Share by Application (2021-2032) Figure 48. Europe HMO Formula Revenue Share by Country (2021-2032) Figure 49. Europe HMO Formula Sales Share by Country (2021-2032) Figure 50. China HMO Formula Revenue Share by Type (2021-2032) Figure 51. China HMO Formula Sales Share by Type (2021-2032) Figure 52. China HMO Formula Revenue Share by Application (2021-2032) Figure 53. China HMO Formula Sales Share by Application (2021-2032) Figure 54. Asia HMO Formula Revenue Share by Type (2021-2032) Figure 55. Asia HMO Formula Sales Share by Type (2021-2032) Figure 56. Asia HMO Formula Revenue Share by Application (2021-2032) Figure 57. Asia HMO Formula Sales Share by Application (2021-2032) Figure 58. Asia HMO Formula Revenue Share by Country (2021-2032) Figure 59. Asia HMO Formula Sales Share by Country (2021-2032) Figure 60. SAMEA HMO Formula Revenue Share by Type (2021-2032) Figure 61. SAMEA HMO Formula Sales Share by Type (2021-2032) Figure 62. SAMEA HMO Formula Revenue Share by Application (2021-2032) Figure 63. SAMEA HMO Formula Sales Share by Application (2021-2032) Figure 64. SAMEA HMO Formula Revenue Share by Country (2021-2032) Figure 65. SAMEA HMO Formula Sales Share by Country (2021-2032) Figure 66. HMO Formula Value Chain Figure 67. Manufacturing Cost Structure Figure 68. HMO Formula Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Abbott
  • Mead Johnson (Reckitt)
  • Nestlé
  • Danone
  • FrieslandCampina(Friso)
  • Yili Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HMO Formula Market by Type
  3. 1.2.1 Global HMO Formula Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Powder
  5. 1.2.3 Liquid
  6. 1.3 HMO Formula Market by Application
  7. 1.3.1 Global HMO Formula Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Online Sales
  9. 1.3.3 Offline Sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 HMO Formula Market Dynamics
  1. 2.1 HMO Formula Industry Trends
  2. 2.2 HMO Formula Industry Drivers
  3. 2.3 HMO Formula Industry Opportunities and Challenges
  4. 2.4 HMO Formula Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global HMO Formula Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global HMO Formula Revenue by Region
  3. 3.2.1 Global HMO Formula Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HMO Formula Revenue by Region (2021-2026)
  5. 3.2.3 Global HMO Formula Revenue by Region (2027-2032)
  6. 3.2.4 Global HMO Formula Revenue Market Share by Region (2021-2032)
  7. 3.3 Global HMO Formula Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global HMO Formula Sales by Region
  9. 3.4.1 Global HMO Formula Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global HMO Formula Sales by Region (2021-2026)
  11. 3.4.3 Global HMO Formula Sales by Region (2027-2032)
  12. 3.4.4 Global HMO Formula Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global HMO Formula Revenue by Manufacturers
  2. 4.1.1 Global HMO Formula Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global HMO Formula Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global HMO Formula Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HMO Formula Sales by Manufacturers
  6. 4.2.1 Global HMO Formula Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global HMO Formula Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global HMO Formula Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global HMO Formula Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global HMO Formula Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global HMO Formula Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global HMO Formula Manufacturers, Product Type & Application
  13. 4.7 Global HMO Formula Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global HMO Formula Market CR5 and HHI
  16. 4.8.2 2025 HMO Formula Tier 1, Tier 2, and Tier 3
5 HMO Formula Market by Type
  1. 5.1 Global HMO Formula Revenue by Type
  2. 5.1.1 Global HMO Formula Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global HMO Formula Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global HMO Formula Revenue Market Share by Type (2021-2032)
  5. 5.2 Global HMO Formula Sales by Type
  6. 5.2.1 Global HMO Formula Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HMO Formula Sales by Type (2021-2032) & (kt)
  8. 5.2.3 Global HMO Formula Sales Market Share by Type (2021-2032)
  9. 5.3 Global HMO Formula Price by Type
6 HMO Formula Market by Application
  1. 6.1 Global HMO Formula Revenue by Application
  2. 6.1.1 Global HMO Formula Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global HMO Formula Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global HMO Formula Revenue Market Share by Application (2021-2032)
  5. 6.2 Global HMO Formula Sales by Application
  6. 6.2.1 Global HMO Formula Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global HMO Formula Sales by Application (2021-2032) & (kt)
  8. 6.2.3 Global HMO Formula Sales Market Share by Application (2021-2032)
  9. 6.3 Global HMO Formula Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott HMO Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott HMO Formula Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Mead Johnson (Reckitt)
  8. 7.2.1 Mead Johnson (Reckitt) Company Information
  9. 7.2.2 Mead Johnson (Reckitt) Business Overview
  10. 7.2.3 Mead Johnson (Reckitt) HMO Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mead Johnson (Reckitt) HMO Formula Product Portfolio
  12. 7.2.5 Mead Johnson (Reckitt) Recent Developments
  13. 7.3 Nestlé
  14. 7.3.1 Nestlé Company Information
  15. 7.3.2 Nestlé Business Overview
  16. 7.3.3 Nestlé HMO Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nestlé HMO Formula Product Portfolio
  18. 7.3.5 Nestlé Recent Developments
  19. 7.4 Danone
  20. 7.4.1 Danone Company Information
  21. 7.4.2 Danone Business Overview
  22. 7.4.3 Danone HMO Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Danone HMO Formula Product Portfolio
  24. 7.4.5 Danone Recent Developments
  25. 7.5 FrieslandCampina(Friso)
  26. 7.5.1 FrieslandCampina(Friso) Company Information
  27. 7.5.2 FrieslandCampina(Friso) Business Overview
  28. 7.5.3 FrieslandCampina(Friso) HMO Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 FrieslandCampina(Friso) HMO Formula Product Portfolio
  30. 7.5.5 FrieslandCampina(Friso) Recent Developments
  31. 7.6 Yili Group
  32. 7.6.1 Yili Group Company Information
  33. 7.6.2 Yili Group Business Overview
  34. 7.6.3 Yili Group HMO Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Yili Group HMO Formula Product Portfolio
  36. 7.6.5 Yili Group Recent Developments
8 North America
  1. 8.1 North America HMO Formula Market Size by Type
  2. 8.1.1 North America HMO Formula Revenue by Type (2021-2032)
  3. 8.1.2 North America HMO Formula Sales by Type (2021-2032)
  4. 8.1.3 North America HMO Formula Price by Type (2021-2032)
  5. 8.2 North America HMO Formula Market Size by Application
  6. 8.2.1 North America HMO Formula Revenue by Application (2021-2032)
  7. 8.2.2 North America HMO Formula Sales by Application (2021-2032)
  8. 8.2.3 North America HMO Formula Price by Application (2021-2032)
  9. 8.3 North America HMO Formula Market Size by Country
  10. 8.3.1 North America HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America HMO Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America HMO Formula Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe HMO Formula Market Size by Type
  2. 9.1.1 Europe HMO Formula Revenue by Type (2021-2032)
  3. 9.1.2 Europe HMO Formula Sales by Type (2021-2032)
  4. 9.1.3 Europe HMO Formula Price by Type (2021-2032)
  5. 9.2 Europe HMO Formula Market Size by Application
  6. 9.2.1 Europe HMO Formula Revenue by Application (2021-2032)
  7. 9.2.2 Europe HMO Formula Sales by Application (2021-2032)
  8. 9.2.3 Europe HMO Formula Price by Application (2021-2032)
  9. 9.3 Europe HMO Formula Market Size by Country
  10. 9.3.1 Europe HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe HMO Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe HMO Formula Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China HMO Formula Market Size by Type
  2. 10.1.1 China HMO Formula Revenue by Type (2021-2032)
  3. 10.1.2 China HMO Formula Sales by Type (2021-2032)
  4. 10.1.3 China HMO Formula Price by Type (2021-2032)
  5. 10.2 China HMO Formula Market Size by Application
  6. 10.2.1 China HMO Formula Revenue by Application (2021-2032)
  7. 10.2.2 China HMO Formula Sales by Application (2021-2032)
  8. 10.2.3 China HMO Formula Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HMO Formula Market Size by Type
  2. 11.1.1 Asia HMO Formula Revenue by Type (2021-2032)
  3. 11.1.2 Asia HMO Formula Sales by Type (2021-2032)
  4. 11.1.3 Asia HMO Formula Price by Type (2021-2032)
  5. 11.2 Asia HMO Formula Market Size by Application
  6. 11.2.1 Asia HMO Formula Revenue by Application (2021-2032)
  7. 11.2.2 Asia HMO Formula Sales by Application (2021-2032)
  8. 11.2.3 Asia HMO Formula Price by Application (2021-2032)
  9. 11.3 Asia HMO Formula Market Size by Country
  10. 11.3.1 Asia HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia HMO Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia HMO Formula Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HMO Formula Market Size by Type
  2. 12.1.1 SAMEA HMO Formula Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA HMO Formula Sales by Type (2021-2032)
  4. 12.1.3 SAMEA HMO Formula Price by Type (2021-2032)
  5. 12.2 SAMEA HMO Formula Market Size by Application
  6. 12.2.1 SAMEA HMO Formula Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA HMO Formula Sales by Application (2021-2032)
  8. 12.2.3 SAMEA HMO Formula Price by Application (2021-2032)
  9. 12.3 SAMEA HMO Formula Market Size by Country
  10. 12.3.1 SAMEA HMO Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA HMO Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA HMO Formula Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 HMO Formula Value Chain Analysis
  2. 13.1.1 HMO Formula Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 HMO Formula Production Mode & Process
  6. 13.2 HMO Formula Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 HMO Formula Distributors
  9. 13.2.3 HMO Formula Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.